Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Prediction market trading surged to a record $4.8 billion in daily volume on June 12 as the World Cup group stages got under way, after opening-day activity of $2.2 billion on June 11. The jump in volume followed the United States match against Paraguay and already surpasses last season's Super Bowl total of $1.4 billion. Polymarket's U.S. platform…
U.S. equities climbed on Friday following a strong initial public offering for SpaceX’s rocket unit and hopes of a diplomatic truce between the U.S. and Iran, pushing the S&P 500, Nasdaq and Dow higher. Attention now shifts to the Federal Open Market Committee meeting this week - the first under Fed Chair Kevin Warsh - where policy guidance and upd…
Dyadic International highlights growing interest in its proprietary C1 protein production platform driven by intensified Ebola virus outbreak preparedness and expanding commercial adoption across multiple markets. The platform's rapid development capabilities support expedited vaccine antigen and monoclonal antibody production, aligning with global…
Fox Corp. has reached an agreement to acquire Roku Inc. in a transaction that values Roku at about $22 billion in enterprise value. The deal, structured as a mix of cash and Fox Class A shares, will pay $160.00 per Roku share, including $96.00 in cash and 0.9693 Fox shares per Roku share. The combination joins Fox’s live sports and news portfolio w…
UBS changed its recommendation on Soitec from "neutral" to "sell," while setting a new €85 price target and sharply reducing its fiscal 2027 gross margin forecast to 19.4% from 30%. The bank warns that the market may be overestimating Soitec's ability to match the growth of downstream silicon photonics customers and highlights inventory destocking …
U.S. index futures climbed sharply after Washington and Tehran confirmed a preliminary peace deal that could reopen critical Middle Eastern shipping lanes. The Nasdaq 100 led gains, with Micron, Nebius and several crypto-exposed stocks posting notable premarket moves. Traws Pharma plunged after a negative regulatory review forced a trial postponeme…
Russian authorities on June 15 dismissed accusations from Kyiv and Western governments that Russian forces struck the 1,000-year-old Pechersk Lavra monastery in Kyiv. Moscow's Defence Ministry denied targeting the site and suggested a U.S.-made Patriot air defence missile was responsible, while the Foreign Ministry called the allegations a "crude f…
SpaceX's public debut cleared a high bar, but the mix of recurring Starlink revenue, growing commercial and government launch backlog, and Starship's scaling potential still looks underappreciated by public markets. This trade targets continued re-rating over the next 180 trading days with a clear entry, stop, and price target calibrated for an inv…
Tripadvisor has reached an agreement to sell its European restaurant booking platform TheFork to American Express in an all-cash transaction valued at $700 million. Shares of Tripadvisor jumped about 14% on the news. The company said the sale will allow it to sharpen focus on its Experiences strategy and could support capital returns, balance-sheet…
Smartphone revenue pressure and new CPU/GPU competition are valid near-term concerns for Qualcomm. Still, Qualcomm's licensing cash flows, strong free cash generation, and positioning to supply AI-capable SoCs for edge and infrastructure make it a tactical long. Entry at $222.40, stop $185.00, target $260.00 — mid-term trade (45 trading days) with …
President Volodymyr Zelenskiy said he proposed meeting Russian President Vladimir Putin during the G7 summit in France to pursue talks aimed at ending the four-year war, but that Moscow was not prepared to engage. Zelenskiy spoke at a Kyiv monastery damaged in overnight attacks that killed at least 10 people. He said securing additional air defence…
Retail participants in the SpaceX initial public offering confronted steeper restrictions on so-called flipping than large institutional buyers. Broker platforms set 15- to 30-day hold windows and punishments ranging from temporary suspensions to permanent bans for accounts that sell too soon, while some large asset managers and hedge funds have lo…
Shipping firms in Asia and Europe welcomed a U.S.-Iran framework to reopen the Strait of Hormuz but say confidence will take weeks to rebuild. Industry groups and carriers want clear evidence of safety, including mine clearance and normalized insurance, before vessels return to regular routing. Limited transit was visible on Monday, while global oi…
Lifecore Biomedical announced a new agreement with a global pharmaceutical company to perform tech transfer and commercial manufacturing for a neurological injectable suspension. This marks Lifecore's seventh late-stage pipeline addition in seven months, underscoring strong business momentum and expertise in complex injectable products, particularl…
Carolyn E. Taylor, a director at Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), purchased 1,415 shares of the company's common stock on June 12, 2026, at $10.55 per share, totaling $14,928. Following this acquisition, her total holdings increased to 1,833 shares. The transaction occurs as TNXP trades at $11.35, reflecting a 64% decline over the…
Pasithea Therapeutics announced its participation as an exhibitor at the Children's Tumor Foundation 2026 NF Conference to engage with the neurofibromatosis type 1 (NF1) community following recent FDA Fast Track and Rare Pediatric Disease Designations for PAS-004, their next-generation macrocyclic MEK inhibitor. The company is currently conducting …
Morgan Stanley describes the recent equity pullback as a digestion of a peak in the rate of change in earnings revisions breadth (ERB) and liquidity, arguing this creates room for a broader leadership set. Strategist Michael Wilson says the earnings bull market remains intact, and the firm identifies Consumer Discretionary Goods, Transports and Reg…
IREN Limited has completed the acquisition of Nostrum Group, a Spain-based AI data center developer, marking its entry into the European market and significantly boosting its AI cloud infrastructure capacity with 490MW of secured grid-connected power and a strong local team.
Lightbridge Corporation announced CEO Seth Grae's participation in upcoming investor and nuclear industry events, discussing the impact of advanced nuclear fuel technology on increasing reactor output and supporting clean energy goals. The company emphasizes its partnerships with US national labs and its patented nuclear fuel technology aimed at im…
Elicio Therapeutics announced that its Phase 2 AMPLIFY-7P study of ELI-002 7P immunotherapy in adjuvant mKRAS-driven pancreatic cancer did not meet the primary disease-free survival endpoint in the intent-to-treat population. However, post-hoc analyses revealed a significant benefit in patients with R0 resection, who represent the majority of the s…
Seer, Inc.'s Board of Directors has issued a letter to shareholders ahead of the July 28, 2026 Annual Meeting, urging a vote in favor of the current board slate amid activist investor attempts to replace directors and push for a sale. The letter highlights Seer's pioneering leadership in proteomics technology, ongoing large-scale scientific studies…
Axsome Therapeutics presented new clinical data on its sleep disorder medicines AXS-12 and solriamfetol at SLEEP 2026, highlighting positive cognitive, functional, and quality-of-life outcomes in narcolepsy and obstructive sleep apnea patients. These presentations reinforce Axsome's leadership in central nervous system disorder treatments and its i…
Lexeo Therapeutics announced the finalization of the SUNRISE-FA 2 pivotal trial protocol and statistical plan for its gene therapy candidate LX2006 in treating Friedreich Ataxia cardiomyopathy. The open-label study aims to support a Biologics License Application to the FDA under the accelerated approval pathway targeted for 2028. Enrollment is on t…
Gogo Inc. announced that its Gogo Galileo connectivity system has received Supplemental Type Certificates from both the FAA and EASA for installation on Dassault Falcon 7X and 8X aircraft. This approval enables the installation of Gogo's high-performance inflight internet service powered by the Eutelsat OneWeb LEO network, offering reliable speeds …
TransAlta Corporation's subsidiary, TransAlta Centralia Generation LLC, has been mandated by the U.S. Department of Energy to keep Centralia Unit 2 in Washington State available for operation until September 13, 2026. The company will comply with this order and coordinate with the DOE and local government accordingly.
